Delving into the Latest Updates on Demotech, Inc. with Synapse

Overview

Tags

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

单次给药：主要目的：比较中国健康受试者单次使用DM0201贴与Lidoderm®的药代动力学特征；次要目的：比较DM0201贴与Lidoderm®在中国健康受试者中单次给药的安全性、耐受性与粘附性。多次给药：主要目的：比较中国健康受试者多次使用DM0201贴与Lidoderm®的药代动力学特征；次要目的：比较DM0201贴与Lidoderm®在中国健康受试者中多次给药的安全性、耐受性与粘附性。

[Translation]

Single administration: Primary purpose: To compare the pharmacokinetic characteristics of DM0201 patch and Lidoderm® in Chinese healthy subjects after single administration; Secondary purpose: To compare the safety, tolerability and adhesion of DM0201 patch and Lidoderm® in Chinese healthy subjects after single administration. Multiple administration: Primary purpose: To compare the pharmacokinetic characteristics of DM0201 patch and Lidoderm® in Chinese healthy subjects after multiple administration; Secondary purpose: To compare the safety, tolerability and adhesion of DM0201 patch and Lidoderm® in Chinese healthy subjects after multiple administration.

Start Date-

Sponsor / Collaborator

Yabao Pharmaceutical Co. Ltd. Beijing

[+1]

100 Clinical Results associated with Demotech, Inc.

Login to view more data

0 Patents (Medical) associated with Demotech, Inc.

Login to view more data

100 Deals associated with Demotech, Inc.

Login to view more data

100 Translational Medicine associated with Demotech, Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data